TransMedics (TMDX) Free Cash Flow (2018 - 2026)

TransMedics' Free Cash Flow history runs 9 years deep, the most recent figure standing at -$12.1 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 59.44% year-over-year to -$12.1 million in Q1 2026; TTM through Mar 2026 was $151.4 million, a 128.06% increase from a year earlier, with the FY2025 full-year figure at $133.6 million, up 174.57% from the prior year.
• Free Cash Flow declined to -$12.1 million in Q1 2026 per TMDX's latest filing, from $19.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $135.7 million in Q4 2024 and bottomed at -$143.5 million in Q4 2023.
• The 5-year median for Free Cash Flow is -$9.5 million (2022), against an average of -$3.1 million.
• Across the five-year window, Free Cash Flow plunged 2010.44% in 2023 and surged 1512.29% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at -$6.8 million in 2022, then plunged by 2010.44% to -$143.5 million in 2023, then surged by 194.54% to $135.7 million in 2024, then slumped by 85.99% to $19.0 million in 2025, then slumped by 163.81% to -$12.1 million in 2026.
• Per Business Quant, the three latest TMDX Free Cash Flow figures stand at -$12.1 million (Q1 2026), $19.0 million (Q4 2025), and $25.8 million (Q3 2025).